309 related articles for article (PubMed ID: 30925428)
1. Organometallic ruthenium(II)-arene complexes with triphenylphosphine amino acid bioconjugates: Synthesis, characterization and biological properties.
Pernar M; Kokan Z; Kralj J; Glasovac Z; Tumir LM; Piantanida I; Eljuga D; Turel I; Brozovic A; Kirin SI
Bioorg Chem; 2019 Jun; 87():432-446. PubMed ID: 30925428
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxic activities of organometallic Ru(II) diamine complexes.
Kavukcu SB; Şahin O; Seda Vatansever H; Kurt FO; Korkmaz M; Kendirci R; Pelit L; Türkmen H
Bioorg Chem; 2020 Jun; 99():103793. PubMed ID: 32278205
[TBL] [Abstract][Full Text] [Related]
4. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
5. Design of Ru-arene Complexes for Antitumor Drugs.
Su W; Li Y; Li P
Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
[TBL] [Abstract][Full Text] [Related]
6. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands.
Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F
Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875
[TBL] [Abstract][Full Text] [Related]
7. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
8. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
[TBL] [Abstract][Full Text] [Related]
9. Understanding the interactions of diruthenium anticancer agents with amino acids.
Nazarov AA; Mendoza-Ferri MG; Hanif M; Keppler BK; Dyson PJ; Hartinger CG
J Biol Inorg Chem; 2018 Oct; 23(7):1159-1164. PubMed ID: 30046902
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes.
Chen J; Peng F; Zhang Y; Li B; She J; Jie X; Zou Z; Chen M; Chen L
Eur J Med Chem; 2017 Nov; 140():104-117. PubMed ID: 28923379
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
[TBL] [Abstract][Full Text] [Related]
13. Effect of cysteine thiols on the catalytic and anticancer activity of Ru(II) sulfonyl-ethylenediamine complexes.
Chen F; Romero-Canelón I; Habtemariam A; Song JI; Banerjee S; Clarkson GJ; Song L; Prokes I; Sadler PJ
Dalton Trans; 2022 Mar; 51(11):4447-4457. PubMed ID: 35226015
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.
Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ
Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456
[TBL] [Abstract][Full Text] [Related]
15. Dinuclear Organoruthenium Complexes Exhibiting Antiproliferative Activity through DNA Damage and a Reactive-Oxygen-Species-Mediated Endoplasmic Reticulum Stress Pathway.
Zhao J; Li S; Wang X; Xu G; Gou S
Inorg Chem; 2019 Feb; 58(3):2208-2217. PubMed ID: 30675781
[TBL] [Abstract][Full Text] [Related]
16. Dissimilar effect of organometallic ruthenium complexes on the viability of MDR and non-MDR experimental models.
Opačak S; Kovač MP; Landais C; Debeljak Ž; Golding TM; Smith GS; Brozovic A; Kirin SI
J Inorg Biochem; 2024 Aug; 257():112614. PubMed ID: 38781850
[TBL] [Abstract][Full Text] [Related]
17. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of zwitterionic half-sandwich Rhodium(III) and Ruthenium(II) organometallic complexes.
Guo L; Hu X; Yang Y; An W; Gao J; Liu Q; Liu Z
Bioorg Chem; 2021 Nov; 116():105311. PubMed ID: 34474302
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
Selvamurugan S; Ramachandran R; Viswanathamurthi P
Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
